TIAA-CREF Individual & Institutional Services’s Moderna MRNA Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$304K	Buy	+1,580	New	+$170K	﹤0.01%	592

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Theleme Partners London, United Kingdom $2.62B AUM 125.04% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's MRNA Position: Q3 2026 in Review

TIAA-CREF Individual & Institutional Services opened a new position in Moderna (MRNA) in Q3 2026: 1,580 shares worth $304K. The stake represents ﹤0.01% of the portfolio and ranks #592 among its holdings.

858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

TIAA-CREF Individual & Institutional Services held 1,580 shares of Moderna worth $304K as of Q3 2026.
Moderna was a new TIAA-CREF Individual & Institutional Services position in Q3 2026.
Moderna made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q3 2026, its #592 holding.
858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q3 2026, filed 12 Nov 2026.